Cameron Firth > Macfarlanes LLP > London, England > Lawyer Profile

Steered by seasoned competition expert Malcolm Walton, Macfarlanes LLP is routinely engaged in high-stakes disputes arising from regulatory investigations, collective damages proceedings, and precedent-setting appeals. Cameron Firth enjoys a stellar reputation in the market – and the pharmaceuticals sector especially – on account of his broad capabilities in merger control matters, dawn raids and inspections, and contentious matters before the English and EU courts. Simon Day is similarly well regarded for his expertise in group litigation, handling numerous individual and collective damages actions for clients in the transport, automotive, and banking sectors. Emma Radcliffe, who was promoted to partner in May 2021, is noted for her proficiency in investigations before both the European Commission and the CMA, as well as follow-on claims at the High Court and in the CAT. Senior counsel Caja Griesenbach maintains a keen focus on jurisdiction challenges.

Macfarlanes LLP‘s combination of ‘excellent legal knowledge and commercial acumen‘ makes them a strong choice for a wide variety of clients, ranging from pharmaceutical companies to industrial manufacturers. Steered by practice head Malcolm Walton, the team regularly advises on cross-jurisdictional merger control actions, FDI proceedings, and high-stakes investigations instigated by the CMA, among other relevant authorities. Cameron Firth is widely lauded by peers and clients alike for his capabilities in CMA investigations and merger control matters, most notably in the pharmaceutical sector. The ‘excellent‘ Tom Usher is recommended for his ‘unparalleled’ competition knowledge in the financial services and broadcasting sectors, while Emma Radcliffe draws equal praise for her work in cross-border cartel investigations. Simon Day specialises in private damage actions for competition law breaches, including collective and individual claims.